Protagonist Therapeutics, Inc - Common Stock (PTGX)
CUSIP: 74366E102
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 62,457,444
- Total 13F shares
- 57,464,862
- Share change
- -519,811
- Total reported value
- $1,317,641,644
- Put/Call ratio
- 17%
- Price per share
- $22.93
- Number of holders
- 155
- Value change
- +$12,220,647
- Number of buys
- 65
- Number of sells
- 77
Quarterly Holders Quick Answers
What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics, Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74366E102:
Top shareholders of PTGX - Protagonist Therapeutics, Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
9.2%
|
5,744,848
|
$95,824,065 | — | 30 Sep 2023 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
8.7%
|
5,446,430
|
$90,846,452 | — | 30 Sep 2023 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
8.7%
|
5,415,514
|
$90,330,774 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.4%
|
5,229,425
|
$87,226,810 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
6.3%
|
3,942,138
|
$65,754,862 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.2%
|
3,228,394
|
$53,849,612 | — | 30 Sep 2023 | |
| JOHNSON & JOHNSON |
13F
|
Company |
3.9%
|
2,449,183
|
$40,852,372 | — | 30 Sep 2023 | |
| Kynam Capital Management, LP |
13F
|
Company |
2.9%
|
1,818,657
|
$30,335,199 | — | 30 Sep 2023 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
2.7%
|
1,657,551
|
$27,647,950 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
1,181,256
|
$19,705,847 | — | 30 Sep 2023 | |
| BRAIDWELL LP |
13F
|
Company |
1.8%
|
1,109,150
|
$18,500,622 | — | 30 Sep 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.8%
|
1,108,140
|
$18,483,775 | — | 30 Sep 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.7%
|
1,054,273
|
$17,585,274 | — | 30 Sep 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.5%
|
941,274
|
$15,701,368 | — | 30 Sep 2023 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
1.3%
|
835,561
|
$13,937,157 | — | 30 Sep 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.3%
|
831,993
|
$13,879,000 | — | 30 Sep 2023 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.2%
|
732,784
|
$12,222,837 | — | 30 Sep 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.1%
|
700,000
|
$11,676,000 | — | 30 Sep 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
1%
|
630,000
|
$10,508,400 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.9%
|
562,688
|
$9,385,635 | — | 30 Sep 2023 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.89%
|
554,305
|
$9,173,748 | — | 30 Sep 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.86%
|
536,024
|
$8,940,881 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
0.82%
|
509,242
|
$8,494,156 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.75%
|
467,203
|
$7,792,946 | — | 30 Sep 2023 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
0.7%
|
439,314
|
$7,327,758 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.7%
|
439,102
|
$7,324,221 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.69%
|
429,004
|
$7,155,788 | — | 30 Sep 2023 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.64%
|
400,000
|
$6,672,000 | — | 30 Sep 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.56%
|
350,281
|
$5,842,687 | — | 30 Sep 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.54%
|
336,308
|
$5,609,617 | — | 30 Sep 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
320,000
|
$5,337,600 | — | 30 Sep 2023 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.51%
|
319,534
|
$5,329,827 | — | 30 Sep 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.51%
|
316,900
|
$5,285,892 | — | 30 Sep 2023 | |
| Gratus Capital, LLC |
13F
|
Company |
0.47%
|
292,869
|
$4,885,055 | — | 30 Sep 2023 | |
| Eversept Partners, LP |
13F
|
Company |
0.46%
|
286,748
|
$4,782,957 | — | 30 Sep 2023 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.4%
|
248,127
|
$4,138,758 | — | 30 Sep 2023 | |
| David Y. Liu |
3/4/5
|
Chief R&D Strategy Officer |
—
class O/S missing
|
167,590
|
$4,127,742 | — | 16 Nov 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.38%
|
239,038
|
$3,987,153 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.37%
|
232,290
|
$3,874,596 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.36%
|
226,268
|
$3,774,000 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.32%
|
201,444
|
$3,360,086 | — | 30 Sep 2023 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.3%
|
184,347
|
$3,074,908 | — | 30 Sep 2023 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.29%
|
180,462
|
$3,010,106 | — | 30 Sep 2023 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.28%
|
177,125
|
$2,954,000 | — | 30 Sep 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.28%
|
176,837
|
$2,949,641 | — | 30 Sep 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.25%
|
154,098
|
$2,570,354 | — | 30 Sep 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.24%
|
147,828
|
$2,465,771 | — | 30 Sep 2023 | |
| TWINBEECH CAPITAL LP |
13F
|
Company |
0.24%
|
147,346
|
$2,457,731 | — | 30 Sep 2023 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.23%
|
143,964
|
$2,401,320 | — | 30 Sep 2023 | |
| GREAT LAKES ADVISORS, LLC |
13F
|
Company |
0.23%
|
141,559
|
$2,361,204 | — | 30 Sep 2023 |
Institutional Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q4 2023
As of 31 Dec 2023,
Protagonist Therapeutics, Inc - Common Stock (PTGX) was held by
155 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,464,862 shares.
The largest 10 holders included
BVF INC/IL, FARALLON CAPITAL MANAGEMENT LLC, BlackRock Inc., RTW INVESTMENTS, LP, VANGUARD GROUP INC, STATE STREET CORP, Point72 Asset Management, L.P., JOHNSON & JOHNSON, Kynam Capital Management, LP, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
155
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
142
Q4 2023 holders
155
Holder diff
13
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.